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Introduction
Oligodendroglioma, a subtype of gliomas, account 
for 4.2% of all primary brain tumors.1,2 Gliomas are 
the most malignant of human brain tumors, and also 
the most common type of primary brain tumor.3-6 
Oligodendroglioma tumors have a high sensitivity to 
chemotherapy; usually, they respond positively to the 
treatment.7,8 The relevant genes and proteins conveying 
the favorable clinical effects associated with of 1p, 19q 
and oligodendroglioma tumors are still unknown.9-11
Tubulin is a heterodimer protein (100 Da), consisting 
of microtubules (alpha and beta) polypeptide chains. 
In human, alpha tubulin has 6 subunit genes, and also 
beta-tubulin has seven subunit genes, that expressed in 
different types of tissues.12,13 However, in the nucleation of 
microtubules in a eukaryotic cell, γ-tubulin has a function. 
γ-Tubulin is a major protein in eukaryotic cells, that 
present and effective in centrosome and cytoplasm.14 The 
structure of alpha and beta tubulin is highly dynamic.15,16 
Microtubules are critically involved in cellular processes, 
mitosis, intracellular transport, the scheduled cell death 
(apoptosis), the mechanism of cancer formation, and 
also cancer treatment (chemotherapy, radiation therapy, 
and anti-tumor drugs).17,18 These microtubules has 
primary and essential functions in the cytoskeleton and 
may provide an attachment site for contractile proteins. 
Microtubules are cytoskeletal hollow fibers present in 
most eukaryotic cells that have cancer treatment users. 
Tubulin acetylated in ε amino, that conserved lys40.
19-21 
Previous reports demonstrated, intermediate filament 
proteins contain motifs (the motifs are short) that causes 
the connection of non-polymerizes tubules and that 
peptides include 24 amino acids, the ability and capacity 
binding to sites maintain tubulin.22
The proteomics research deals with systematic analysis 
of protein profiles of the proteins expressed in  given 
cell, tissue, and biological system at a given time, and 
then compare the conditions differently.23-25 As proven 
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in previous research, the proteome contains proteins 
resulting from the translation of the genome, as well as 
the proteins resulting from changes after translation. 
These are the backbone of protein biomarkers.26,27 Cancer 
biomarkers for the early detection of malignancies and 
choice of appropriate treatment has requested in the 
different kinds of diseases.28 Proteomics has produced 
types of biomarker candidates for cancer, But this is 
important, that biomarkers are specific.29-31 The 2DE and 
MS are suitable methods for proteomics research, which 
analyzed the proteome of the glioma tissue and standard 
brain samples. Alteration in expression proteome 
detected, also showed most changes in expression levels of 
proteins related to metabolism, cytoskeleton, proteasome, 
and immune systems.32,33 Advanced proteome imaging 
techniques included isoelectric focusing (IEF) approach, 
immobilized pH gradient (IPG) gel, gel trypsin digestion, 
and then MALDI-TOF-TOF analysis For proteins 
identification.34,35
In this article, we investigated the alpha-tubulin 
expression change in oligodendroglioma tumor. We 
extracted proteins and separated proteins using 2DE, 
analyzed the software, then identified alternation in 
oligodendroglioma of alpha-tubulin by statistical data, 




Tissues were obtained, with informed consent and 
institutional review board approval, from patients 
undergoing tumor resection. For this study, all 
individuals filled a written informed consent form. 
Oligodendroglioma tumors were surgically removed 
and then classified [according to the World Health 
Organization (WHO)] at the hospital. The control tissue 
obtained from the margin of confidence around the 
tumor.
Tissue and Sample Preparation
The following protocol used for protein extraction and 
preparation of tumor tissue samples: tissue samples 
were washed with PBS, cell lysis by sonication (samples 
received 3 rounds of sonication, and each round lasted 
30 seconds), acetone (50% and 100%) wash at 4°C, 15000 
g, and three rounds of 30 minutes each. In the following, 
the obtained pellet kept on -20°C overnight. Protein 
solubilization following acetone removal by adding 1ml 
of rehydration buffer and 50 μL of a protease inhibitor to 
each protein pellet containing tubes. Finally, the Bradford 
assay used for the analysis of each tissue sample protein 
content. 
Two-Dimensional Gel Electrophoresis
Two-dimensional gel electrophoresis for protein 
separation was performed with IPG strips (18 cm) by IEF. 
IPG trips had then transformed to SDS-PAGE gel and 
proteins were further separated based on their molecular 
weight. Followed by a final coomassie blue staining of the 
SDS-PAGE gel.
SDS-PAGE Scan and Bioinformatics analysis
We used Scanner [densitometer GS-800 (BioRad)] to 
scan gels. Followed by a primary analysis of 2D images 
by Quantity One® software. The obtained scanned 
images of SDS-PAGE gels has further analyzed by Non-
Linear Dynamics Progenesis Same Spot® Software. After 
comparing the obtained 2D images with control samples, 
first protein detection was performed based on the 
protein bands. 
SDS-PAGE gels were scanned using scanner Densitometer 
GS-800 (BioRad) scanner at 600 dpi in tagged image file 
format (TIFF). ImageMasterTM 2D platinum v6.0 software 
was then used to extract and digitize data from graphical 
images of scanned gels through detecting, normalizing, 




MS was used to confirm the early protein detection results 
obtained by analysis of 2D image analysis. The identity 
of differentially expressed proteins was established using 
MS. The calculation standard in this study is fold more 
than two.
Statistical Analysis, Clustering, and PCA
The obtained results were statistically analyzed by t test 
(P<0.05), and SPSS version 19.
Protein spots with P<0.05 divided into 2 groups: 
increased and decreased protein expression groups. Then, 
clustering was used to identify the location of significantly 
significant spots, followed by PCA in determining 
the accuracy of the obtained results. Cluster analysis 
performed on two groups. 
1. Proteins that have increased expression
2. Protein that has decreased expression
Results
Electrophoresis and MALDI-TOF-TOF Analysis
We compared protein expression patterns between 
oligodendroglioma samples relative to control, using 
2DGE and MALDI-TOF-TOF proteomics analysis. The 
2DE showed 1328 spots. A total of 433 spots showed 
statistically significant differences in the image, alpha-
tubulin (2 spots of total spots) were identified using the 
data obtained from MS in conjunction with a search of 
the databank (NCBI, www.ncbi.nlm.nih.gov/protein). 
MALDI-TOF-TOF results revealed that those two spots 
represent a total of up-regulated proteins. Among them 
the statistically significant protein spots alpha-tubulin 
proteins were definitely with pHi: 4.94 and MW: 50804 Da 
detected which has an up-regulation about 3.1 (fold=3.1) 
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for the first spot, and (second spot) pHi: 5.02 and MW: 
50810 Da detected which has an up-regulation about 
2 (fold=2) for the second spot, in oligodendroglioma 
tumors than control (Figure 1). Comparison of spot alpha 
tubulin between healthy tissue and tumor differentially 
expressed spot in oligodendroglioma tumor (Figure 2).
In this experiment, we saw changes in alpha-tubulin 
expression (up-regulated) in oligodendroglioma 
tumor than control identified by MALDI-TOF-TOF. 
Levels of alpha-tubulin spots were markedly higher in 
oligodendroglioma than non-tumor. We analyzed data 
from the MALDI-TOF-TOF, were shown in Table 1. 
Also, the position of the peptide presented has shown in 
Figure 3. Then, peptides that match the information in 
the databank searching obtained as shown in Table 2.
Spots Clustering
Spots statistical analysis have commonly used nonlinear 
Progenesis Samespots software in which the change in 
protein levels. Accordingly, proteins has classified into 2 
Figure 1. (First spot) alpha-tubulin protein has an up-regulation about 3.1 
(fold=3.1) in oligodendroglioma brain tumor than normal brain tissue. 
(Second spot) alpha-tubulin protein has an up-regulation about 2 (fold=2) 
in oligodendroglioma brain tumor than normal brain tissue.
Figure 2. 3D Images of Alpha-Tubulin Protein in Oligodendroglioma 
Tumor Tissue.
Table 1. Analyzed Data by MALDI-TOF-TOF for Alpha-Tubulin in Oligodendroglioma Tumor Than Control
Observed Mr (expt) Mr (calc) PPM Score Expect
gi340021 1023.4638 1022.4565 1022.4417 14.5 58 0.0013
1085.6414 1084.6341 1084.6128 19.6 69 8.6e-05
1410.8043 1409.7970 1409.7667 21.5 96 1.9e-07
1487.9089 1486.9017 1486.8719 20.0 93 2.4e-07
1701.9344 1700.9272 1700.8985 16.8 119 7.6e-10
1718.9132 1717.9059 1717.8747 18.2 60 0.00072
1756.9852 1755.9780 1755.9559 12.5 121 5e-10
2409.1929 2408.1856 2408.2012 -6.49 185 1.7e-16
gi37492 1457.8995 1456.8923 1456.8613 21.2 81 3e-06
categories: proteins that have increased expression and 
proteins that have reduced expression. Alpha-tubulin 
identified by MALDI-TOF-TOF, then it was identified 
in the expression increased group (red), alpha tubulin 
position in the clustering was determined by isoelectric 
pH and molecular weight. We have identifand alpha-
tubulin position and was shown in Figure 4.
For more understanding about rates of change, each of 
the tumors has compared with the controls. MW and pHi 
values recorded in Table 3. Then, statistical analysis has 
shown in Table 4. 
Discussion
Proteomics and proteome analysis approach have allowed 
biology and medical studies of protein expression for 
different goals in different tissues, serum, CSF, urine and 
all biological fluids in despite conditions and types of 
Time.36,37 For more understanding, the protein molecular 
mechanisms involved in rabies pathogenesis different 
proteomics approach has used including proteome analysis 
of several in vitro, and in vivo host models infected with 
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different cancer related to protein, for example, dynamic 
alterations, phosphorylation, trafficking and localization, 
and protein-protein interactions. Phosphorylation 
and nuclear localization of protein cells involved in 
cancer may be clinical potential cancer biomarkers.28,38 
Actually, changes after translation such as acetylation 
and phosphorylation for tubulin is affecting the variety 
of diseases. These changes can be useful in diseases of 
the nervous system and neurodegenerative diseases. 
The acetylation of α tubulin plays an essential role in 
regulating stability and structure microtubule, specific 
tubulin function such as can division and intracellular 
trafficking.39,40 The protein dynamic structures because 
of the interaction of alpha and beta tubulins polymers 
with associated microtubule. Microtubule has different 
functions in cells, such as cell motility, maintenance of cell 
shape, mitosis, and organization.41,42
Changes made to the amino acids cause may Cause 
the decrease of a specific contact with an interesting 
molecule.43,44 The desire to change of a protein molecule 
or a lipid molecule depends on its basic structure and 
modifications of the peptide resulting from the sequence 
modification.45 It is necessary to remember that small 
peptides line neurofilament (NFL) lightweight (about 
61 kDa) tubulin binding sites. For example, the basic 
structure of tubulin is not known in complete detail, but 
protein baby related to the peptide [Gly-(Glu) 3-Gly-
(Glu) 2 Y] that cause carboxy terminus of tyrosylated 
alpha-tubulin. It forms the ends of the amino acids (8 last 
Figure 3.  MALDI-TOF-TOF showed the position of the peptide for alpha-
tubulin in oligodendroglioma tumor.
Figure 4. The alpha-tubulin position has shown in the diagram cluster.
Table 2. Alpha-Tubulin Protein Matching the Same Set of Peptides By Databank Searching
Tubulin Alpha Mass Score Matches Sequences
gi14389309 1C chain 50548 801 8(8) 8(8)
gi3474335 1B chain 50804 801 8(8) 8(8)
gi62897609 6 Variant 50476 801 8(8) 8(8)
gi193786502 Unnamed 46725 801 8(8) 8(8)
gi193787715 Unnamed 46825 801 8(8) 8(8)
gi296211572 1B chain isoform 2 46797 801 8(8) 8(8)
gi221039556 Unnamed 58636 799 8(8) 8(8)
gi6755901 1A chain 50788 789 8(8) 8(8)
gi73996547 1 isoform 9 46781 789 8(8) 8(8)
amino acids) in alpha-tubulin.46,47 The carboxy terminus 
of proteins structure, modifications peptide are essential 
for tubulin function.48
Alpha-tubulin can also be separated and identified by 
electrophoresis (IEF and SDS-PAGE) and spectroscopy 
(MALDI-TOF-TOF). The resulting examined by 
software, protein database, and tubulin isotype specific 
tryptic peptides identified. It is such important human 
tubulin in different isotype include α3, α4, α6, α8, Kα1, and 
bα1. In all isotopes, post-translational modifications might 
create. α4 tubulin was in the brain.
12,49 Alpha-tubulin 
isotype has a tyrosine or phenylalanine residue, which 
encoded at the end, but not exclusive. Researchers have 
shown that tyrosine accounts for a significant percentage 
of α4 tubulin, That is the reason functional α4 tubulin 
tyrosine ligase. The importance of the differences in 
tubulin can contribute to the biological recognition of the 
cytoskeleton system and the ways of rapid diagnosis and 
treatment of cancer.12,20,50,51 Tubulin was tyrosinatation and 
acetylation (lys40), was lower them the level of detection. 
Researchers have been investigating the correction of 
tubulin and post-transplantation in gliomas (astrocytoma 
and oligodendroglioma) and various types of cancer. 49
We have shown changes in expression of proteins by 
clustering of alpha-tubulin related to oligodendroglioma; 
All the spots divided into 2 main clusters, Increase and 
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decrease expression, indicate that alpha tubulin placed 
in a cluster, which has an increased expression. This 
increase in alpha-tubulin expression is consistent with 
other studies, but with different overexpression. We have 
shown that alpha-tubulin as being a potential candidate 
for a biomarker of the diagnosis and prediction of 
oligodendroglioma tumors presented.
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